栄研化学(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4549/E00961 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2014/05/02 | 日証協 | 106,653株 | -10.11% | 2,431株 | -56.91% | 174,111株 | -16.38% | 200株 | -93.55% |
| 2014/04/25 | 日証協 | 118,653株 | -5.87% | 5,642株 | -62.39% | 208,212株 | -2.44% | 3,101株 | +106.73% |
| 2014/04/18 | 日証協 | 126,053株 | -21.1% | 15,003株 | +5.63% | 213,411株 | -23.29% | 1,500株 | -97.4% |
| 2014/04/11 | 日証協 | 159,753株 | -8.53% | 14,203株 | +9.61% | 278,216株 | -2.83% | 57,790株 | -19.52% |
| 2014/04/04 | 日証協 | 174,650株 | +60.89% | 12,958株 | -35.2% | 286,313株 | +81.2% | 71,805株 | +423.97% |
| 2014/03/28 | 日証協 | 108,550株 | -10.92% | 19,997株 | -73.58% | 158,007株 | -35.01% | 13,704株 | -94.01% |
| 2014/03/20 | 日証協 | 121,853株 | +97.32% | 75,700株 | +350.6% | 243,111株 | +249.24% | 228,700株 | +9999.99% |
| 2014/03/14 | 日証協 | 61,753株 | -2.98% | 16,800株 | -25.18% | 69,611株 | -7.2% | 1,000株 | -77.27% |
| 2014/03/07 | 日証協 | 63,653株 | +12.75% | 22,455株 | +148.26% | 75,011株 | -0.06% | 4,400株 | -20% |
| 2014/02/28 | 日証協 | 56,453株 | +1.26% | 9,045株 | +249.23% | 75,056株 | +0.13% | 5,500株 | -41.77% |
| 2014/02/21 | 日証協 | 55,753株 | +2.2% | 2,590株 | -85.44% | 74,956株 | +6.64% | 9,445株 | +295.19% |
| 2014/02/14 | 日証協 | 54,553株 | -9.84% | 17,790株 | -17.26% | 70,291株 | -5.08% | 2,390株 | -68.55% |
| 2014/02/07 | 日証協 | 60,507株 | +33.12% | 21,500株 | +27.22% | 74,055株 | +14.28% | 7,600株 | -49.33% |
| 2014/01/31 | 日証協 | 45,453株 | -1.2% | 16,900株 | +179.15% | 64,801株 | -1% | 15,000株 | -0.87% |
| 2014/01/24 | 日証協 | 46,007株 | -3.56% | 6,054株 | -46.24% | 65,455株 | -4.52% | 15,132株 | +90.48% |
| 2014/01/17 | 日証協 | 47,707株 | -3.24% | 11,262株 | -6.21% | 68,555株 | -1.44% | 7,944株 | -76.96% |
| 2014/01/10 | 日証協 | 49,307株 | +3.35% | 12,008株 | +606.35% | 69,555株 | -6.08% | 34,476株 | +545.13% |
| 2013/12/30 | 日証協 | 47,707株 | -1.65% | 1,700株 | -80.92% | 74,055株 | -1.99% | 5,344株 | -86.11% |
| 2013/12/27 | 日証協 | 48,507株 | -0.61% | 8,908株 | -36.51% | 75,555株 | +4.86% | 38,476株 | +12.91% |
※株式分割は考慮していませんのでご注意ください。
Page Top